Search clinical trials for: 10-217

Total 12617 results

Memorial Sloan Kettering Cancer Center

Withdrawn

Prospective Analysis of Changes in Background Parenchymal Enhancement (BPE) and Amount of Fibroglandular Tissue on Breast MRI

Breast Cancer
Biogen

Terminated

A Study to Evaluate SAGE-217 for Prevention of Relapse in Adult Participants With Major Depressive Disorder

Major Depressive Disorder

United States
The University of Texas Medical Branch, Galveston
National Institute on Drug Abuse (NIDA); UConn Health

Completed

Bupropion for Smoking Cessation During Pregnancy

Tobacco Use Disorder | Pregnancy Related

United States
Biogen

Completed

A Study to Evaluate the Efficacy and Safety of SAGE-217 in Participants With Severe Postpartum Depression (PPD)

Depression, Postpartum

United States, Spain, United Kingdom
University of Rochester

Completed

Interactive Cholesterol Advisory Tool (ICAT)

Low Risk (0-10% Chance) of Developing Cardiovascular Disease Within 10 Years Based on Risk Factors | Moderate Risk (10-20% Chance) of Developing Cardiovascular (Heart) Disease Within 10 Years Based on Risk Factors

United States
Biogen

Completed

A Study to Assess the Pharmacodynamic Effects of SAGE-217 in Healthy Adults Using an Insomnia Model

Healthy

United States
Pfizer

Completed

A Study To Investigate The Effect Of PD-217,014 On Abdominal Pain/Discomfort In Patients With IBS.

Irritable Bowel Syndrome
University of California, Merced

Completed

Parents' View About Discussing Health Behaviors

Parents of Children Ages 10 to 17 Years Old

United States
Biocad

Recruiting

A Clinical Study of BCD-217 (Nurulimab + Prolgolimab) Followed by Anti-PD-1 Compared to Anti-PD-1 Monotherapy as First-Line Treatment in Subjects With Unresectable/Metastatic Melanoma (OCTAVA)

Melanoma | Melanoma (Skin) | Melanoma Stage IV | Melanoma Stage III | Melanoma Metastatic | Melanoma Unresectable | Melanoma Advanced

India, Russian Federation, Belarus
Children's Hospital of Philadelphia
State Farm Insurance Co.; Bryn Mawr Rehabilitation Hospital; GFK Knowledge Networks

Completed

An Evaluation of a Web-based Intervention Program for Parents and Teens to Promote Safe Driving

Novice Teen Driver Training

United States
20/10 Perfect Vision

Unknown

Intrastromal Correction of Ametropia by a Femtosecond Laser (ISCAF)

Presbyopia | Astigmatism | Myopia | Hyperopia

Germany
Riphah International University

Completed

Effects of High Intensity Interval Training on Cognitive Flexibility Among Female Teenagers

Cognitive Flexibility Among Female Teenagers

Pakistan
Gérond'if

Recruiting

Validity of Using Connected Soles In Measuring Steps Number In the Older Subject, Hospitalized in Follow-up and Rehabilitative Care and Achieve Its Rehabilitation Objectives (SEMCOPAGE)

Patient Recovering Maximum Walking Capacity, Over 10 Meter

France
Gérond'if

Withdrawn

Validity of Using Connected Soles In Measuring Steps Number In the Older Subject, Hospitalized in Follow-up and Rehabilitative Care and Achieve Its Rehabilitation Objectives (SEMCOPAGE)

Patient Recovering Maximum Walking Capacity, Over 10 Meters
Teesside University
University of Sunderland

Recruiting

The Effect of 6 Weeks Jump Training on Sand Versus Hard Surfaces on Jump Landing and Performance in Young Females

Frontal Plane Projection Angle | Maximal Countermovement Jump | Repeated 10/5

United Kingdom
Biogen

Completed

A Study to Evaluate SAGE-217 in Participants With Severe Postpartum Depression

Postpartum Depression

United States
Biogen

Completed

A Study to Evaluate the Efficacy of Sage-217 in the Treatment of Adult Participants With Major Depressive Disorder (MDD)

Depressive Disorder, Major

United States
Biocad

Active, not recruiting

Study of Efficacy and Safety of BCD-217 (Anti-CTLA-4 and Anti-PD-1) Followed By BCD-100 (Anti-PD-1) Versus BCD-100 Monotherapy as First-Line Treatment in Patients With Unresectable or Metastatic Melanoma (OBERTON)

Melanoma | Melanoma Metastatic

Russian Federation, Belarus
Chang Gung Memorial Hospital

Completed

Delta Shock Index in Predicting Massive Transfusion

Trauma Patients Received Blood Transfusion ≥ 10 U | Trauma Patients Had Not Received Blood Transfusion ≥ 10 U

Taiwan
Sage Therapeutics
Biogen

Completed

A Study to Evaluate SAGE-217 in Adult Participants With Major Depressive Disorder (MDD)

Major Depressive Disorder

United States
Assiut University

Unknown

Amplification of Zinc Finger Protein 217 Gene in Multiple Myeloma

Multiple Myeloma
AnaptysBio, Inc.

Recruiting

A Study to Evaluate the Efficacy and Safety of Rosnilimab (ANB030) in Treatment of Subjects With Moderate-to-Severe Alopecia Areata (AZURE)

Alopecia Areata

United States
AnaptysBio, Inc.

Completed

A Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Participants With Acne Vulgaris

Acne Vulgaris

United States, Canada
Minia University Hospital

Recruiting

Dexmedetomidine on Postoperative Cognitive Dysfunction and Serum Tau-217 Protein.

Cognitive Impairment

Egypt
Sage Therapeutics
Biogen

Recruiting

Zuranolone Pharmacokinetics (PK) and Safety Study Adolescent Participants With Major Depressive Disorder (MDD)

Major Depressive Disorder

United States
Université de Sherbrooke
University of Toronto; Université de Montréal

Completed

A Randomized, Non-inferiority Clinical Trial of CVA Telerehabilitation Treatments - TelePhysioTaiChi

Stroke

Canada
Biogen

Terminated

A Study to Evaluate the Safety, Tolerability, and Efficacy of SAGE-217 Compared to Placebo in Adult Participants With Comorbid Major Depressive Disorder (MDD) and Insomnia

Insomnia | Major Depressive Disorder

United States
University Hospital, Grenoble

Terminated

Educ'Avk: Recommendations for the Antivitamin K's Gestion

AVK Treatment

France
Yonsei University

Recruiting

Biobank of Lung Ultrasonography in Children Undergoing General Anesthesia

Children Aged 6 Months to 10 Years Old Under General Anesthesia

Korea, Republic of
Biogen

Completed

A Study to Evaluate SAGE-217 in Participants With Bipolar I/II Disorder With a Current Major Depressive Episode

Bipolar Disorder I | Major Depressive Episode | Bipolar Disorder II

United States
Biogen

Completed

A Study to Evaluate the Efficacy of SAGE-217 in the Treatment of Adult Participants With Major Depressive Disorder

Major Depressive Disorder

United States
Schön Klinik Berchtesgadener Land

Completed

Cardiorespiratory Response During Whole Body Vibration Training in Patients With Chronic Lung Disease

Chronic Obstructive Lung Disease (n=10) | Interstitial Lung Disease (n=10)

Germany
Biogen

Completed

A Study to Evaluate SAGE-217 in Participants With Moderate to Severe Major Depressive Disorder

Major Depression

United States
Biogen

Completed

A Comparative Study of Sage-217 Plus an Antidepressant (ADT) Versus Placebo Plus an ADT in Adults With Major Depressive Disorder

Depressive Disorder, Major

United States
AnaptysBio, Inc.

Completed

A Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Subjects With Hidradenitis Suppurativa

Hidradenitis Suppurativa

United States, Canada, Georgia, Poland
AnaptysBio, Inc.

Recruiting

A Study of Efficacy and Safety of Rosnilimab in Subjects With Moderate to Severe Ulcerative Colitis (ROSETTA)

Ulcerative Colitis

United States, Georgia
National University Hospital, Singapore
Tan Tock Seng Hospital

Unknown

Reducing Nephrotoxicity of Vancomycin: A Prospective Study of Continuous Versus Intermittent Infusion of Vancomycin

Infections Requiring Prolonged Duration (>10 Days) of Vancomycin

Singapore
Cosmo Technologies Ltd

Recruiting

Study to Evaluate Maximum Tolerated Dose of Oral CB-03-10 With Dose Expansion Phase, in Advanced Solid Tumors

Advanced Refractory Solid Tumors | Subjects Considered Likely to Respond to CB-03-10

United States
Auburn University

Completed

Active Play Intervention for Preschoolers (Active Play)

Exercise

United States
Massachusetts General Hospital

Withdrawn

Evaluating the Effect of Isotretinoin in Regulatory T-cell Function in Adverse Cutaneous Drug Eruptions (ACDEs): A Pilot Study

Toxic Epidermal Necrolysis

United States
Unity Health Toronto

Not yet recruiting

Optimal Resection Technique for Medium-sized (10-20mm) Colorectal Polyps

10-20mm Colorectal Polyp
Biogen

Completed

A Study to Evaluate SAGE-217 in Participants With Essential Tremor

Essential Tremor

United States
AnaptysBio, Inc.

Recruiting

This Study Will Evaluate the Safety, Tolerability, and Efficacy of ANB032 in Subjects With Moderate to Severe Atopic Dermatitis (AD).

Atopic Dermatitis Eczema

Georgia, United States, Australia, Canada, Czechia, New Zealand, Poland
Guangdong Provincial People's Hospital

Completed

Evaluation of the Screening Effect of Artificial Intelligence Hand Activity Evaluation System for Cervical Spondylosis

10-second G&R Test

China
National Cancer Institute (NCI)

Completed

Vaccine Therapy in Treating HLA-A2 Positive Patients With Melanoma

Recurrent Melanoma | Stage IIIA Melanoma | Stage IIIB Melanoma | Stage IIIC Melanoma | Stage IIB Melanoma | Stage IIC Melanoma | Stage IA Melanoma | Stage IB Melanoma | Stage IIA Melanoma

United States
Assistance Publique - Hôpitaux de Paris

Completed

Does Hypnosis Improve Severe Sleepwalking ? (HYPNOSOM)

Sleepwalking

France
Gazi University

Recruiting

The Effect of the Rubber Hand Illusion on Sensory Thresholds

Healthy

Turkey
St. Petersburg State Pavlov Medical University

Completed

OPTIMAL STENTS DURING RENAL COLIC

Ureteral Stent Occlusion

Russian Federation
Memorial Sloan Kettering Cancer Center
Johns Hopkins University; Dana-Farber Cancer Institute; Sheba Medical Center; Shaare... and other collaborators

Recruiting

A Registry for BRCA Mutation Carriers With Pancreatic Ductal Adenocarcinoma

Pancreatic Ductal Adenocarcinoma

United States, Israel
Asir John Samuel

Completed

Reliability and Validity of 10 Meters Walk Test Among Children

The Study Focuses to Find the Intrarater Reliability, Test-retest Reliability and Validity of 10 Meters Walk Test Among Middle School Going Children

India

Search clinical trials for: 10-217

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Georgia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations